Search Results - "Yuda, Sayako"

Immunohistochemical CD20-negative change in B-cell non-Hodgkin lymphomas after rituximab-containing therapy by Maeshima, Akiko Miyagi, Taniguchi, Hirokazu, Fujino, Takahiro, Saito, Yo, Ito, Yuta, Hatta, Shunsuke, Yuda, Sayako, Makita, Shinichi, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Maruyama, Dai, Izutsu, Koji

“…CD20 − change after rituximab-containing therapy is considered one of the main reasons of rituximab resistance of B-cell non-Hodgkin lymphomas (B-NHLs)…”
Get full text

Non–diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases by Maeshima, Akiko Miyagi, Taniguchi, Hirokazu, Ida, Hanae, Hosoba, Rika, Fujino, Takahiro, Saito, Yo, Yuda, Sayako, Makita, Shinichi, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Maruyama, Dai, Izutsu, Koji

“…Diffuse large B-cell lymphoma (DLBCL) is the most common histological transformation (HT) of follicular lymphoma (FL). Other types of HT are very rare, and…”
Get full text

Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab by Ito, Yuta, Makita, Shinichi, Maeshima, Akiko Miyagi, Hatta, Shunsuke, Suzuki, Tomotaka, Yuda, Sayako, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Maruyama, Dai, Izutsu, Koji

“…Paraneoplastic pemphigus (PNP) is a severe autoimmune blistering disease associated with an underlying malignancy, and its prognosis is poor. We herein report…”
Get full text

Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997–2016 by Maeshima, Akiko Miyagi, Taniguchi, Hirokazu, Suzuki, Tomotaka, Yuda, Sayako, Toyoda, Kosuke, Yamauchi, Nobuhiko, Makita, Shinichi, Fukuhara, Suguru, Munakata, Wataru, Maruyama, Dai, Kobayashi, Yukio, Tobinai, Kensei

“…We analyzed the distribution of tumors and lymphomas of the anterior mediastinum diagnosed between 1997 and 2016 at the National Cancer Center Hospital, Japan…”
Get full text

Comparison of clinicopathologic characteristics of gastric follicular lymphomas and duodenal follicular lymphomas by Maeshima, Akiko Miyagi, MD, Taniguchi, Hirokazu, MD, Suzuki, Tomotaka, MD, Yuda, Sayako, MD, Toyoda, Kosuke, MD, Yamauchi, Nobuhiko, MD, Makita, Shinichi, MD, Fukuhara, Suguru, MD, Munakata, Wataru, MD, Maruyama, Dai, MD, Kobayashi, Yukio, MD, Saito, Yutaka, MD, Tobinai, Kensei, MD

“…We compared the incidence, esophagogastroduodenoscopy (EGD) findings, and histopathologic characteristics of gastric and duodenal follicular lymphomas (FL). Of…”
Get full text

Biomarker discordance between primary breast cancer and bone or bone marrow metastases by Yuda, Sayako, Shimizu, Chikako, Yoshida, Masayuki, Shiino, Sho, Kinoshita, Takayuki, Maeshima, Akiko Miyagi, Tamura, Kenji

“…Discordance in biomarker expression between primary and metastatic tumor sites has been reported in several studies; yet, few have examined this feature in…”
Get full text

Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors by Suzuki, Tomotaka, Fukuhara, Suguru, Nomoto, Junko, Yamashita, Satoshi, Maeshima, Akiko M, Ito, Yuta, Hatta, Shunsuke, Yuda, Sayako, Makita, Shinichi, Munakata, Wataru, Suzuki, Tatsuya, Maruyama, Dai, Taniguchi, Hirokazu, Ushijima, Toshikazu, Izutsu, Koji, Tobinai, Kensei, Kobayashi, Yukio

Get full text

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation by Yuda, Sayako, Fuji, Shigeo, Savani, Bipin, Gatwood, Katie S.

“…Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment strategy in patients with a hematological disorder. Chemotherapy-induced…”
Get full text

Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients by Maeshima, Akiko Miyagi, Taniguchi, Hirokazu, Ito, Yuta, Hatta, Shunsuke, Suzuki, Tomotaka, Yuda, Sayako, Makita, Shinichi, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Maruyama, Dai, Izutsu, Koji

“…We analyzed the clinicopathologic characteristics of 136 intestinal diffuse large B-cell lymphomas (DLBCLs) among 126 patients. The DLBCL sites were…”
Get full text

The outcome of watchful waiting in patients with previously treated follicular lymphoma by Fujino, Takahiro, Maruyama, Dai, Maeshima, Akiko‐Miyagi, Saito, Yo, Ida, Hanae, Hosoba, Rika, Yuda, Sayako, Makita, Shinichi, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Kuroda, Junya, Izutsu, Koji

“…Watchful waiting (WW) is one of the standard approaches for newly diagnosed follicular lymphoma (FL) patients with low‐tumor burden. However, the impact of WW…”
Get full text

EBV‐encoded RNA1‐positive cells in the bone marrow specimens of patients with EBV‐negative lymphomas and sarcomas by Ito, Yuta, Makita, Shinichi, Maeshima, Akiko Miyagi, Hatta, Shunsuke, Yuda, Sayako, Suzuki, Tomotaka, Fukuhara, Suguru, Munakata, Wataru, Taniguchi, Hirokazu, Suzuki, Tatsuya, Maruyama, Dai, Izutsu, Koji

“…Epstein‐Barr virus (EBV) infection is associated with pathogenesis of various cancers, including extranodal natural killer/T‐cell lymphoma, nasal type (ENKL)…”
Get full text

A case of multiple myeloma with pancreatic involvement diagnosed via endoscopic ultrasound‐guided fine needle aspiration by Hiraga, Erika, Yamai, Takuo, Ikezawa, Kenji, Kawamoto, Yasuharu, Hirao, Takeru, Higashi, Sena, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Nakabori, Tasuku, Uehara, Hiroyuki, Ryu, Ayumi, Yuda, Sayako, Honma, Keichiro, Ohkawa, Kazuyoshi

“…This report highlights the importance of considering multiple myeloma in the differential diagnosis of a pancreatic tumor with bone lesions. sampling not only…”
Get full text

Clinicopathological analysis of primary refractory diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy by Suzuki, Tomotaka, Maruyama, Dai, Miyagi‐Maeshima, Akiko, Nomoto, Junko, Tajima, Kinuko, Ito, Yuta, Hatta, Shunsuke, Yuda, Sayako, Makita, Shinichi, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Taniguchi, Hirokazu, Izutsu, Koji, Kobayashi, Yukio, Tobinai, Kensei

“…Background Approximately 15% of patients with diffuse large B‐cell lymphoma (DLBCL) experience refractory or early relapsed disease after initial…”
Get full text

Strategies to minimize toxicities during chemoradiotherapy for esophageal cancer by Yuda, Sayako, Kato, Ken

Get more information

Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation by Saburi, Masuho, Kohashi, Sumiko, Kato, Jun, Koda, Yuya, Sakurai, Masatoshi, Toyama, Takaaki, Kikuchi, Taku, Karigane, Daiki, Yuda, Sayako, Yamane, Yusuke, Hashida, Risa, Abe, Ryohei, Nakazato, Tomonori, Hirahashi, Junichi, Ogata, Masao, Okamoto, Shinichiro, Mori, Takehiko

“…Calcineurin inhibitors (CIs) such as cyclosporine A (CSA) and tacrolimus often cause renal dysfunction, resulting in increased serum creatinine, hyperkalemia,…”
Get full text

Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin by Nakai, Ritsuko, Fukuhara, Suguru, Maeshima, Akiko Miyagi, Kim, Sung‐Won, Ito, Yuta, Hatta, Shunsuke, Suzuki, Tomotaka, Yuda, Sayako, Makita, Shinichi, Munakata, Wataru, Suzuki, Tatsuya, Maruyama, Dai, Izutsu, Koji

“…This is the first case report of alectinib as a bridge to allo‐SCT in a patient with ALK‐positive ALCL refractory to both conventional chemotherapies and BV…”
Get full text

Sodium-losing nephropathy caused by tacrolimus after allogeneic hematopoietic stem cell transplantation by Yuda, Sayako, Mori, Takehiko, Kato, Jun, Koda, Yuya, Kohashi, Sumiko, Kikuchi, Taku, Saburi, Masuho, Okamoto, Shinichiro

“…A 39-year-old woman (Case 1) and a 57-year-old woman (Case 2) underwent allogeneic bone marrow transplantation for acute lymphoblastic leukemia and follicular…”
Get more information

Persistently Low IgG2 Levels in a Subset of Patients Following Hematopoietic Cell Transplantation by Fuji, Shigeo, Suga, Makiko, Tada, Yuma, Shingai, Yasuhiro, Kasahara, Hidenori, Yuda, Sayako, Yokota, Takafumi, Ishikawa, Jun

“…ABSTRACT Background Infectious diseases remain a major cause of morbidity and mortality after hematopoietic cell transplantation (HCT). Secondary…”
Get full text

MO37-5 Hematologic toxicities induced by Immune checkpoint inhibitors: a single-center, retrospective study by Yuda, Sayako, Yuma, Tada, Yasuhiro, Shingai, Shigeo, Fuji, Hiroaki, Masaie, Jun, Ishikawa

Get full text

A single-institution pre-post comparison of subcutaneous immunoglobulin replacement therapy in allogeneic haematopoietic cell transplantation recipients by Suga, Makiko, Fuji, Shigeo, Tada, Yuma, Tsutsumi, Kazuhito, Kida, Shuhei, Shibata, Kumi, Nakata, Ryo, Shingai, Yasuhiro, Yuda, Sayako, Yokota, Takafumi, Ishikawa, Jun

“…Immunoglobulin replacement therapy (IgRT) reduces the risk of infection in hypogammaglobulinaemia secondary to chronic lymphocytic leukaemia and multiple…”
Get full text